JPRN-UMIN000026783
Completed
N/A
A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasis - A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasis
agoya University0 sites20 target enrollmentMay 1, 2017
ConditionsGastric cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Gastric cancer
- Sponsor
- agoya University
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) HER2 IHC 3\+, or IHC 2 and FISH\+ 2\) Uncontrolled diabetes 3\) Uncontrolled hypertension 4\) Unstable angina pectoris, or a history of myocardial infarction within six months 5\) Chronic lung disease: interstitial pneumonia, pulmonary fibrosis, or severe emphysema 6\) Synchronous cancers (except for cases whose prognositc facter is gastric cancer) 7\) Systemic infection requiring treatment 8\) Fever above 38 degree Celsius 9\) A possibility of pregnancy or during pregnancy, or lactating women 10\) Psychosis or psychotic symptoms 11\) Continuous systemic administration of steroids (oral or intravenous)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancerrectal cancerJPRN-UMIN000003428Toho University school of medicine20
Completed
N/A
Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus canceresophagus cancerJPRN-UMIN000014305Department of Medical Oncology, Sapporo Medical University School of Medicine28
Completed
Phase 2
Feasibility trial of neoadjuvant chemotherapy with docetaxel,cisplatin and fluorouracil for clinical stage II/III esophageal carcinoma.esophageal neoplasmJPRN-UMIN000002396Saitama Cancer Center40
Completed
N/A
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.JPRN-UMIN000046338Sapporo Medical University24
Completed
N/A
A Prospective Study of Neoadjuvant Chemotherapy with Nivolumab/Gemcitabine/Cisplatin in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderKCT0003804Samsung Medical Center48